Analysts Rate IQVIA Holdings Inc. as a Moderate Buy

IQVIA Holdings Inc. (NYSE:IQV) has received an average recommendation of "Moderate Buy" from the nineteen research firms that cover the company, according to Marketbeat Ratings. Among these analysts, four have suggested holding the stock, while fourteen have given it a buy rating and one analyst has assigned it a strong buy recommendation. The average target price for IQV shares over the next twelve months is set at $256.50, reflecting the optimistic outlook from these analysts.

Recent evaluations from several equity research analysts highlight some adjustments in target price. For instance, JPMorgan Chase & Co. has revised its price objective for IQVIA from $279.00 down to $240.00, maintaining an "overweight" rating in their November 5th research note. Similarly, Redburn Atlantic began coverage on IQVIA on October 14th, issuing a "buy" rating with a price target of $276.00. On the other hand, StockNews.com lowered its rating for IQVIA from "buy" to "hold" on November 28th. Morgan Stanley also adjusted its target price, changing it from $280.00 to $265.00 while keeping an "overweight" rating. Furthermore, Evercore ISI set a new price target of $265.00 after reducing it from $270.00, classifying the stock as "outperform" in their report dated October 8th.

IQVIA Stock Analysis

The trading session on Friday opened with shares of IQV at $202.63. The stock has shown a 50-day moving average of $215.18 and a 200-day moving average of $225.14, indicating its performance trends over time. The company currently holds a quick ratio and current ratio at 0.81, while its debt-to-equity ratio stands at 1.76. With a total market capitalization of approximately $36.78 billion, IQVIA presents a price-to-earnings ratio of 26.59 and a price-to-earnings-growth ratio of 2.06. Over the past year, the stock has experienced a low of $187.62 and reached a high of $261.73.

Institutional Ownership Trends

A significant portion of IQVIA's shares is held by institutional investors, with 89.62% of the stock owned by these entities and hedge funds. Several investors have recently entered positions in IQVIA. For example, Opal Wealth Advisors LLC purchased new shares valued at approximately $27,000 during the second quarter, while Capital Performance Advisors LLP also acquired shares worth about $27,000 in the third quarter. Other investments include Park Place Capital Corp with a stake valued at roughly $28,000, and Itau Unibanco Holding S.A., which bought shares worth around $29,000. International Assets Investment Management LLC completed a new acquisition worth about $32,000 during the second quarter.

Overview of IQVIA Holdings Inc.

IQVIA Holdings Inc. specializes in providing advanced analytics, technology solutions, and clinical research services tailored for the life sciences sector across various regions, including the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three main segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Conclusion

As IQVIA continues to evolve amidst market changes, analysts maintain a generally positive outlook with most suggesting a moderate buy stance. Investors and potential buyers should weigh the recommendations alongside their investment strategies and market conditions.

IQVIA, stocks, analysts